Literature DB >> 1178881

Hypoxic sensitizers: radiobiological studies at the cellular level.

E J Hall, L Roizin-Towle.   

Abstract

The nitroimidazoles have been found to selectively sensitize hypoxic cells to the effects of irradiation. The latest in this family of drugs is RO-07-0582, which is able to mimic 80% of the oxygen effect at a concentration of 5 mM by modifying the sensitivity of hypoxic cells to single doses of gamma rays; however, it is not a substitution for oxygen in promoting the repair of sublethal radiation damage between split doses. Studies show that it is a powerful cytotoxic agent as well and selectively operates against hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178881     DOI: 10.1148/117.2.453

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  50 in total

1.  Cytotoxicity of misonidazole and DNA damage in hypoxic mammalian cells.

Authors:  B Palcic; L D Skarsgard
Journal:  Br J Cancer Suppl       Date:  1978-06

2.  Sensitizing and toxicity properties of misonidazole and its derivatives.

Authors:  G F Whitmore; S Gulyas; A J Varghese
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  The nitroimidazoles as radiosensitizers and cytotoxic agents.

Authors:  E J Hall; R Miller; M Astro; F Rini
Journal:  Br J Cancer Suppl       Date:  1978-06

4.  The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.

Authors:  C J Gomer; R J Johnson; F W Hetzel; G Lawrence
Journal:  Br J Cancer Suppl       Date:  1978-06

5.  Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.

Authors:  P W Sheldon; J F Fowler
Journal:  Br J Cancer Suppl       Date:  1978-06

6.  Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.

Authors:  E O Pettersen
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Enhancement of local tumour control by misonidazole and hyperthermia.

Authors:  H B Stone
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 8.  Cellular approaches to bioreductive drug mechanisms.

Authors:  A M Rauth; R S Marshall; B L Kuehl
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

9.  Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells.

Authors:  I J Stratford; P Gray
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 10.  The experimental development of bioreductive drugs and their role in cancer therapy.

Authors:  P Workman; I J Stratford
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.